Bachem Annual General Meeting 2025

Rhea-AI Summary

Bachem held its Annual General Meeting 2025 with strong shareholder participation of 79.7% of eligible shares. The meeting approved a dividend of CHF 0.85 per share, payable on May 7, 2025, with ex-dividend trading starting May 5, 2025.

Key approvals included the re-election of the Chairman and Board members, with Dr. Simone Wyss Fedele joining as a new board member. Shareholders endorsed the annual report, financial statements, sustainability report, and remuneration report. Forvis Mazars SA was appointed as the new auditor for 2025.

The company's upcoming financial calendar includes:

• Dividend payout: May 7, 2025
• Half-Year Report 2025: July 24, 2025
• Annual Report 2025: March 12, 2026
• Next Annual General Meeting: April 29, 2026

Positive

• Dividend payment of CHF 0.85 per share approved, showing financial stability
• High shareholder participation with 79.7% of eligible shares present at AGM
• All board proposals approved, indicating strong shareholder confidence
• Board strengthened with new member Dr. Simone Wyss Fedele

Negative

• None.

• All proposals of the Board of Directors approved.
• Dividend of CHF 0.85 per share.

Bubendorf, Switzerland--(Newsfile Corp. - April 30, 2025) - Bachem Holding AG (SIX: BANB) (“Bachem”) announced today that its Annual General Meeting 2025 has approved all proposals of the Board of Directors. A total of 79.7% of the 74‘977‘940 eligible shares were present.

The Annual General Meeting approved a dividend of CHF 0.85 per share. The dividend will be paid on May 7, 2025. The last trading day entitling to receive the dividend is May 2, 2025. As of May 5, 2025, the shares will be traded ex-dividend.

Both the Chairman and the other members of the Board of Directors were re-elected for a further year. Dr. Simone Wyss Fedele was elected as a new member of the Board. The existing members of the Compensation Committee were also re-elected for a further year.

The shareholders approved the annual report, the financial statements of Bachem Holding AG, the consolidated financial statements for the business year 2024, as well as the appropriation of retained earnings and reserves from capital contributions and the total amount of the annual compensation paid to the Board of Directors and to the Corporate Executive Committee. Further, the shareholders approved the sustainability report and, in a consultative vote, the remuneration report.

Forvis Mazars SA, Zurich was appointed by the Annual General Meeting as auditor of Bachem Holding AG for the business year 2025.

A detailed list of all resolutions will be made available at 
https://www.bachem.com/about-bachem/investors-and-media/financial-events/.

Financial Calendar

May 7, 2025                Payout date for dividend

July 24, 2025              Publication of Half-Year Report 2025

March 12, 2026          Publication of Annual Report 2025; Media and Analyst conference

April 29, 2026             Annual General Meeting (financial year 2025)

About Bachem

Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with its headquarters in Switzerland and sites in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange. For further information, see www.bachem.com.

For more information 

Media

Dr. Daniel Grotzky
Head Group Communications
Tel.: +41 58 595 2021
Email: media@bachem.com 

Investors

Barbora Blaha
Head Investor Relations
Tel.: +41 58 595 0573
Email: ir@bachem.com

This publication may contain specific forward-looking statements, e.g. statements including terms like "believe", "assume", "expect", "forecast", "project", "may", "could", "might", "will" or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of Bachem Holding AG and those explicitly or implicitly presumed in these statements. Against the background of these uncertainties, readers should not rely on forward-looking statements. Bachem Holding AG assumes no responsibility to up-date forward-looking statements or to adapt them to future events or developments.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/250307

FAQ

What dividend will Bachem (BCHMY) pay in 2025?

Bachem will pay a dividend of CHF 0.85 per share, with the payment date set for May 7, 2025. The last day to be eligible for the dividend is May 2, 2025, and shares will trade ex-dividend starting May 5, 2025.

When is Bachem's (BCHMY) dividend payout date in 2025?

Bachem's dividend payout date is scheduled for May 7, 2025. Shareholders must own shares by May 2, 2025, to receive the dividend payment.

What key proposals were approved at Bachem's 2025 AGM?

At the 2025 AGM, shareholders approved all Board proposals, including the annual report, financial statements, dividend payment, compensation packages, and sustainability report. Dr. Simone Wyss Fedele was elected as a new board member.

What was the shareholder participation rate at Bachem's 2025 AGM?

The shareholder participation rate at Bachem's 2025 Annual General Meeting was 79.7%, representing 74,977,940 eligible shares.

When will Bachem (BCHMY) release its next financial results?

Bachem will publish its Half-Year Report 2025 on July 24, 2025, and the Annual Report 2025 will be released on March 12, 2026, along with a Media and Analyst conference.